CMCSA Stock Chart Thu, Dec 19th, 2013

New Post Public Reply Private Reply Replies (0) Message Board
chartguy89
CMCSA Stock Chart and Technical Analysis - Thu, Dec 19th, 2013 $CMCSA

Period  Moving Average  Price Change  Percent Change  Average Volume
5 Day  49.67  +2.11  +4.34%  10,310,280
20 Day  49.28  +3.93  +8.39%  10,916,405
50 Day  48.12  +6.45  +14.55%  10,073,420
100 Day  45.97  +8.07  +18.89%  10,152,092
200 Day  43.83  +10.16  +25.01%  11,217,051
Year to Date  43.03  +13.42  +35.92%  11,722,421

Period  Raw Stochastic  Stochastic %K  Stochastic %D  Average True Range
9 Day 98.70% 85.54% 75.26% 0.88
14 Day 98.85% 80.24% 61.82% 0.87
20 Day 99.23% 81.53% 69.78% 0.87
50 Day 99.52% 88.93% 81.89% 0.84
100 Day 99.69% 92.40% 87.56% 0.80

Period  Relative Strength  Percent R  Historic Volatility  MACD Oscillator
9 Day 72.85% 1.30% 16.03% +0.68
14 Day 67.71% 1.15% 15.51% +0.80
20 Day 64.89% 0.77% 19.64% +0.75
50 Day 60.26% 0.48% 18.72% +1.91
100 Day 58.10% 0.31% 19.86% +4.06

CMCSA Stock Chart and Technical Analysis - Thu, Dec 19th, 2013
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading